Concept Life Sciences, the integrated drug discovery, development and analytical services company, announced it has appointed Marc Princivalle as Group Head of Toxicology, to support the growth of the company’s integrated discovery and development services.
In this new role, Princivalle will lead the group’s toxicology and safety team, driving Concept’s expansion into areas such as de-risking pre-clinical candidate selection, and investigation of safety and toxicology in the early stages of small molecule discovery. Expansion in these areas is becoming increasingly important to aid successful downstream development.
Princivalle has more than 16 years’ experience in toxicology, with expertise in peptides, small molecule and monoclonal antibodies for various indications such as diabetes, oncology, urology, gynaecology, infertility and dermatology.
He also has cross-industry experience, having worked in senior toxicology roles in cosmetics, fragrances, over-the-counter medicines, tobacco products and e-Cigarettes, as well as drug discovery and development.
Princivalle has a PhD in Biochemistry from the Geneva University Hospital in the field of Reproductive Medicine and is a European Registered Toxicologist.
Paul Doyle, Chief Scientific Officer at Concept Life Sciences, said: “Marc’s appointment brings invaluable expertise and experience to Concept, supporting our mission across the group of delivering knowledge-based and science-led solutions to customers and bringing safety considerations early into the discovery process.
“We are delighted to welcome him at an exciting point in the Company’s growth, as we continue to establish Concept Life Sciences as leading experts in integrated discovery and development.”
